IBA is a global leader in proton therapy solutions for the treatment of cancer.

 

Background

  • Previously limited profile, misunderstood, and share price was under pressure

1/2

of the world’s proton therapy centers installed by IBA

 

Our strategy

  • Brought in to enhance profile, streamline story and strategically position IBA with financial community globally
  • Utilised specialised investor events, financial conferences and analyst relations to enhance understanding

 

Outcome

  • Significant analyst interest and coverage initiated by European and US banks
  • Heightened media profile in Belgium and internationally
  • Enhanced understanding of the potential of the proton therapy market